Company · CIK 1324017

# Meadway Pharmaceuticals Ltd.

| CIK | [1324017](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001324017) (SEC EDGAR) |
| --- | --- |
| Business address | Ireland |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | none on EDGAR |

## Offerings

 0 registrations

No offering chain starts here after 2002-11-04: the company's filings belong to registrations filed earlier, or to drafts and notices only.

## Filings

 2

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2011-06-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1324017/999999999511001941/9999999995-11-001941-index.htm) Declared effective | 333-173144-09 | 9999999995-11-001941 |
| 2007-04-10 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1324017/999999999507001254/9999999995-07-001254-index.htm) Declared effective | 333-140965-12 | 9999999995-07-001254 |

[All filings of this company](https://equitycapital.markets/filings?cik=1324017) · [CSV](https://equitycapital.markets/filings.csv?cik=1324017)

---
Source page: https://equitycapital.markets/company/1324017 · Data: U.S. SEC EDGAR · CC BY 4.0